Polymyositis/Dermatomyositis
2 clinical trials · Condition
◉ Watch Polymyositis/Dermatomyositis
| Record | Firm | Date |
|---|---|---|
| Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases (NCT06888973) | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 2025-02-01 |
| A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis) (NCT06455449) | AstraZeneca | 2024-06-20 |
Track Polymyositis/Dermatomyositis automatically
Every clearance here is in the API, with alerts when new ones post.